Customer Support

3B-NEO is a genome-based screening test designed for healthy newborns. It is especially recommended for infants from birth to within the first three months of life. This period is considered the most critical window because symptoms of genetic disorders often have not yet appeared, and early detection can secure the golden time for treatment—helping prevent disease progression or dramatically improve prognosis.